These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 21406294

  • 1. The roles of the skeleton and phosphorus in the CKD mineral bone disorder.
    Hruska KA, Mathew S.
    Adv Chronic Kidney Dis; 2011 Mar; 18(2):98-104. PubMed ID: 21406294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Function and effect of bone morphogenetic protein-7 in kidney bone and the bone-vascular links in chronic kidney disease.
    Mathew S, Davies M, Lund R, Saab G, Hruska KA.
    Eur J Clin Invest; 2006 Aug; 36 Suppl 2():43-50. PubMed ID: 16884397
    [Abstract] [Full Text] [Related]

  • 4. Osteo-renal regulation of systemic phosphate metabolism.
    Razzaque MS.
    IUBMB Life; 2011 Apr; 63(4):240-7. PubMed ID: 21438115
    [Abstract] [Full Text] [Related]

  • 5. The role of fibroblast growth factor 23 in chronic kidney disease-mineral and bone disorder.
    Diniz H, Frazão JM.
    Nefrologia; 2013 Nov 13; 33(6):835-44. PubMed ID: 24158124
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
    Williams MJ, Sugatani T, Agapova OA, Fang Y, Gaut JP, Faugere MC, Malluche HH, Hruska KA.
    Kidney Int; 2018 Jan 13; 93(1):147-158. PubMed ID: 28843411
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Connections between vascular calcification and progression of chronic kidney disease: therapeutic alternatives.
    Hruska KA, Mathew S, Davies MR, Lund RJ.
    Kidney Int Suppl; 2005 Dec 13; (99):S142-51. PubMed ID: 16336568
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The Importance of Phosphate Control in Chronic Kidney Disease.
    Tsuchiya K, Akihisa T.
    Nutrients; 2021 May 14; 13(5):. PubMed ID: 34069053
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hyperphosphatemia in Chronic Kidney Disease (CKD)].
    Wang J, Zhang XY, Guan YF.
    Sheng Li Ke Xue Jin Zhan; 2015 Aug 14; 46(4):241-4. PubMed ID: 26669072
    [Abstract] [Full Text] [Related]

  • 19. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis.
    Koizumi M, Komaba H, Fukagawa M.
    Contrib Nephrol; 2013 Aug 14; 180():110-23. PubMed ID: 23652554
    [Abstract] [Full Text] [Related]

  • 20. Hyperphosphatemia of chronic kidney disease.
    Hruska KA, Mathew S, Lund R, Qiu P, Pratt R.
    Kidney Int; 2008 Jul 14; 74(2):148-57. PubMed ID: 18449174
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.